论文信息 - Initial results from a phase IIIb/IV study evaluating two dosing regimens of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (CheckMate 511). - 字舞流文

Initial results from a phase IIIb/IV study evaluating two dosing regimens of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (CheckMate 511).

P. Ascierto | M. Smylie | I. Svane | P. Rutkowski | R. Gonzalez | C. Lebbé | A. Menzies | A. Saci | N. Meyer | L. Mortier | I. Márquez-Rodas | L. Rollin | M. Ajaz | C. Robert | J. Pigozzo | E. Grigoryeva | T. Eigentler